EnPress Publisher requests all members involved in the journal publishing process to adhere to the Core Practices on publication ethics as stipulated by the Committee on Publication Ethics (COPE).
EnPress Publisher strictly adheres to the COPE's Ethical Oversight Guidelines and monitors the entire publication process in accordance with the guidelines and best practices, which include Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from the International Committee of Medical Journals Editors (ICMJE) and the Principles of Transparency and Best Practice in Scholarly Publishing developed by the Committee on Publication Ethics (COPE),Directory of Open Access Journals (DOAJ), Open Access Scholarly Publishers Association (OASPA), and World Association of Medical Editors (WAME). The publisher treats all personal information of authors as private and promises to not disclose the information to third parties except as required by law or for necessary purposes of the publishing process. EnPress Publisher promises to oversee the procedures and behavior of authors, editors, and reviewers and to ensure that all participants are without any conflicts of interest for a publication process that is fair and objective. Authors of research works involving humans must provide the ethical approval code or identifiers from the academic ethics committee, and authors should obtain the Informed Consent Statement from the subjects about the publication's purpose and the consequential impact. If the subjects are vulnerable, informed consent should be obtained from their guardian. For more details on EnPress Publisher's policies regarding research works involving humans and animals, please refer to “Research involving humans” and “Research involving animals”.
The publisher's journal editors take all possible misconducts seriously. The editors, authors, or readers can forward their concerns to the publisher if a research work may involve academic fraud, research misconduct, or publication malpractice. Concerns or complaints submitted to the publisher on possible allegations will be dealt with promptly and appropriately according to the procedure set out in the COPE flowchart on complaints. The complainant may direct all inquiries and correspondence to the publisher at manage@enpress-publisher.com.
EnPress Publisher adopts a zero-tolerance policy concerning any academic misconducts and ethical violations in research and publication regardless of the severity of these issues. Violations include plagiarism, falsification of research, data fabrication, submitting manuscripts of others as one's own, submission of the same manuscript to different publication venues at the same time, and breached intellectual property rights. In cases of suspected misconduct and ethical violation, a panel will be formed to investigate the allegation. If the allegation is supported by evidence, the submitted manuscript in question will be declined for consideration in the journal and all authors will be informed of the decision. A retraction initiated by authors or by the journal is required to take place if the paper has already been published, and the retraction will be made public. Authors of the work in question will receive the panel’s decision via email and all appeals regarding the decision will have to be made to the publisher via email to manage@enpress-publisher.com within 30 days of the decision date.
Research Involving Humans
If human subjects were used in the experiment, authors should identify during the submitting process the committee or organization (e.g., author's Institutional Ethics Review Board) that approved the experiment as well as detailed ethical approval information, such as approval identifiers, i.e., reference numbers. EnPress Publisher's journals require that authors provide proof of research ethics or ethics statement along with the submission. In the case that ethical approval identifiers are not available, written approval from the granting committee or organization must be provided as a confidential supplemental file.
The manuscript should confirm that the experiment was carried out in adherence to the ethical principles set out in the WMA Declaration of Helsinki and that informed consent was obtained from all human subjects.
For an investigation undertaken on human subjects, the manner in which informed consent was obtained from the study participants should be stated clearly as well.
Authors should inform study participants of the purpose(s) of the publication, the possible risks and benefits as a result of the experiment, and the patient's right to withhold or withdraw consent. Consent should be obtained from parent(s) or legal guardian(s) if the study participant is a minor.
Authors are obliged to declare and clearly specify any restrictions on the availability or the use of human data in the manuscript.
Research Involving Animals
The procedures of research involving animals, including insects and husbandry, must be carried out in accordance with national and institutional regulations. For further guidance on experiments involving animals, authors can refer to the Code of Practice for the Housing and Care of Animals Used in Scientific Procedures, Three Rs, Core Principles for the Care and Use of Animals in Research, and EU regulations on animal research. If ethical approval is not required by national laws, authors should provide an exemption from the ethics committee if one is available.
EnPress Publisher endorses ARRIVE guidelines for reporting experiments using live animals. Authors and reviewers can use the ARRIVE Essential 10: Compliance Questionnaire as a checklist. Editors reserve the right to reject submissions based on ethics guidelines or animal welfare concerns.
Copyright © by EnPress Publisher. All rights reserved.
